Mirati Therapeutics, Inc. (MRTX) — Analyst outlook / Analyst consensus target is. Based on 31 analyst ratings, the consensus is bullish — 14 Buy, 17 Hold.
The consensus price target is $102.10 (low: $53.00, high: $247.00), representing an upside of 73.9% from the current price $58.70.
MRTX Stock — 12-Month Price Forecast
$102.10
▲ +73.94% Upside
Average Price Target
Based on 31 Wall Street analysts offering 12-month price targets for Mirati Therapeutics, Inc., the average price target is $102.10, with a high forecast of $247.00, and a low forecast of $53.00.
The average price target represents a +73.94% change from the last price of $58.70.
Highest Price Target
$247.00
Average Price Target
$102.10
Lowest Price Target
$53.00
MRTX Analyst Ratings
Hold
Based on 31 analysts giving stock ratings to Mirati Therapeutics, Inc. in the past 3 months
